141 related articles for article (PubMed ID: 20341381)
1. An explosive reaction following the simultaneous administration of sodium arsenite and dithioglycerol (BAL) in vivo.
KOPPANYI T; SPERLING F
Anat Rec; 1946 Dec; 96(4):501. PubMed ID: 20341381
[No Abstract] [Full Text] [Related]
2. Central and autonomic effects following the combined administration of sodium arsenite and 2,3-dimercaptopropanol (BAL).
KOPPANYI T; SPERLING F
J Pharmacol Exp Ther; 1947 Apr; 89(4):350-5. PubMed ID: 20295515
[No Abstract] [Full Text] [Related]
3. DMSA, DMPS, and DMPA--as arsenic antidotes.
Aposhian HV; Carter DE; Hoover TD; Hsu CA; Maiorino RM; Stine E
Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S58-70. PubMed ID: 6327446
[TBL] [Abstract][Full Text] [Related]
4. Amelioration by BAL (2,3-dimercapto-1-propanol) and DMPS (sodium 2,3-dimercapto-1-propanesulfonic acid) of arsenite developmental toxicity in mice.
Domingo JL; Bosque MA; Llobet JM; Corbella J
Ecotoxicol Environ Saf; 1992 Jun; 23(3):274-81. PubMed ID: 1376232
[TBL] [Abstract][Full Text] [Related]
5. Estimation of the body burden of arsenic in a child fatally poisoned by arsenite weedkiller.
Saady JJ; Blanke RV; Poklis A
J Anal Toxicol; 1989; 13(5):310-2. PubMed ID: 2615344
[TBL] [Abstract][Full Text] [Related]
6. Clinical uses of 2,3-dimercaptopropanol (BAL); the effect of BAL on the excretion of arsenic in arsenical intoxication.
LUETSCHER JA; EAGLE H; LONG-COPE WT
J Clin Invest; 1946 Jul; 25(4):534-40. PubMed ID: 21001627
[No Abstract] [Full Text] [Related]
7. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of arsenical dermatitis with preparations of BAL.
LONGCOPE WT; LUETSCHER JA
J Clin Invest; 1946 Jul; 25(4):528-33. PubMed ID: 21001626
[No Abstract] [Full Text] [Related]
8. Arsenic-induced dyslipidemia in male albino rats: comparison between trivalent and pentavalent inorganic arsenic in drinking water.
Afolabi OK; Wusu AD; Ogunrinola OO; Abam EO; Babayemi DO; Dosumu OA; Onunkwor OB; Balogun EA; Odukoya OO; Ademuyiwa O
BMC Pharmacol Toxicol; 2015 Jun; 16():15. PubMed ID: 26044777
[TBL] [Abstract][Full Text] [Related]
9. Contact sensitivity to arsenical compounds. Clinical and experimental studies.
Wahlberg JE; Boman A
Derm Beruf Umwelt; 1986; 34(1):10-2. PubMed ID: 2937622
[TBL] [Abstract][Full Text] [Related]
10. BAL as an antidote to poisoning with sodium arsenite in sheep.
WHITE IG; BLOOD DC; WHITTEM JH
Aust Vet J; 1949 Jan; 25(1):8-11. PubMed ID: 18113385
[No Abstract] [Full Text] [Related]
11. Comparative acute systemic toxicity of sodium arsenite and dichloro(2-chlorovinyl)arsine in rabbits.
Inns RH; Bright JE; Marrs TC
Toxicology; 1988 Oct; 51(2-3):213-22. PubMed ID: 3176029
[TBL] [Abstract][Full Text] [Related]
12. Mass poisoning by sodium arsenite.
Roses OE; García Fernández JC; Villaamil EC; Camussa N; Minetti SA; Martínez de Marco M; Quiroga PN; Rattay P; Sassone A; Valle G
J Toxicol Clin Toxicol; 1991; 29(2):209-13. PubMed ID: 2051508
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of three antidotes on arsenic toxicity in the common earthworm (Lumbricus terrestris).
Li W; Chien PK; Furst A
J Appl Toxicol; 1994; 14(3):181-3. PubMed ID: 7521893
[TBL] [Abstract][Full Text] [Related]
14. Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium.
Suzuki S; Arnold LL; Pennington KL; Chen B; Naranmandura H; Le XC; Cohen SM
Toxicol Appl Pharmacol; 2010 Apr; 244(2):99-105. PubMed ID: 20045014
[TBL] [Abstract][Full Text] [Related]
15. Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms.
Sakurai T; Kaise T; Matsubara C
Chem Res Toxicol; 1998 Apr; 11(4):273-83. PubMed ID: 9548797
[TBL] [Abstract][Full Text] [Related]
16. Arsenite as the probable active species in the human carcinogenicity of arsenic: mouse micronucleus assays on Na and K arsenite, orpiment, and Fowler's solution.
Tinwell H; Stephens SC; Ashby J
Environ Health Perspect; 1991 Nov; 95():205-10. PubMed ID: 1821373
[TBL] [Abstract][Full Text] [Related]
17. [Cutaneous pigmentation in spots; arsenical poisoning? Sensitivity of the skin to sodium arsenite].
CARPENTIER E
Arch Belg Dermatol Syphiligr; 1951 Sep; 7(3):154-5. PubMed ID: 14915515
[No Abstract] [Full Text] [Related]
18. Optical isomers of 2,3-dimercapto-1-propanesulfonate: antidotal activity, in vitro and in vivo, against sodium arsenite.
Hsu CA; Aposhian HV; Heydolph S; Parr W
J Pharmacol Exp Ther; 1983 Feb; 224(2):314-8. PubMed ID: 6687396
[TBL] [Abstract][Full Text] [Related]
19. [Arsenical erythroma extinguished by B.A.L. and sodium thiosulfate].
SMITH H
Union Med Can; 1949 Dec; 78(12):1437. PubMed ID: 15394898
[No Abstract] [Full Text] [Related]
20. Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.
EAGLE H; MAGNUSON HJ; FLEISCHMAN R
J Clin Invest; 1946 Jul; 25(4):451-66. PubMed ID: 21001620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
